Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received August 9, 2012
- Accepted after revision December 2, 2012
- Published online October 8, 2013.
Article Versions
- Latest version (April 11, 2013 - 08:14).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2013 by American Journal of Neuroradiology
Author Information
- J. Barakosa,b,
- R. Sperlingc,
- S. Sallowayd,
- C. Jacke,
- A. Gassf,
- J.B. Fiebachg,
- D. Tampierih,
- D. Melançonh,
- Y. Miauxb,
- G. Ripponi,
- R. Blacki,
- Y. Lua,
- H.R. Brashearj,
- H.M. Arrighij,
- K.A. Morrisj and
- M. Grundmanj,k
- aFrom the California Pacific Medical Center (J.B.), San Francisco, California
- bSynarc (J.B., Y.M.), Newark, California
- cBrigham and Women's Hospital (R.S.), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
- dWarren Alpert Medical School of Brown University (S.S.), Providence, Rhode Island
- eMayo Clinic (C.J.), Rochester, Minnesota
- fUniversity Hospital Mannheim (A.G.), University of Heidelberg, Mannheim, Germany
- gCenter for Stroke Research (J.B.F.), Charité, Berlin, Germany
- hNeuroRx Research (D.T., D.M.), Montreal, Quebec, Canada
- iPfizer Inc (G.R., R.B.), Collegeville, Pennsylvania
- jJanssen Alzheimer Immunotherapy Research & Development, LLC (H.R.B., H.M.A., K.A.M., M.G.), South San Francisco, California
- kGlobal Partners Inc (M.G.), Cambridge, Massachusetts.
- Please address correspondence to Jerome Barakos, MD, California Pacific Medical Center, 2333 Buchanan St, San Francisco, CA 94115; e-mail: barakosmd{at}gmail.com
Altmetrics
Cited By...
Jump to section
Related Articles
Cited By...
- Alzheimer Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for Monitoring of Amyloid-Related Imaging Abnormalities
- Monoclonal Antibodies: What the Diagnostic Neuroradiologist Needs to Know
- Incidence of Amyloid-Related Imaging Abnormalities in Patients With Alzheimer Disease Treated With Anti-{beta}-Amyloid Immunotherapy: A Meta-analysis
- Amyloid-Related Imaging Abnormalities with Emerging Alzheimer Disease Therapeutics: Detection and Reporting Recommendations for Clinical Practice
- Aducanumab Use in Symptomatic Alzheimer Disease Evidence in Focus: A Report of the AAN Guidelines Subcommittee
- Tumefactive Primary Central Nervous System Vasculitis: Imaging Findings of a Rare and Underrecognized Neuroinflammatory Disease
- Leptomeningeal contrast enhancement and blood-CSF barrier dysfunction in aseptic meningitis